Group B Strep (GBS) Online Course
10-hour online course aimed at midwives covering the latest evidence-based information on group B Strep (GBS).
Featuring 5 world-leading experts, this easy-to-understand online course offers go-at-your-own-pace learning with no deadlines.
The course content covers the latest research on:
- Signs and treatment of early-onset and late-onset group B Strep infection
- Universal screening and Risk-based approach to GBS colonisation in pregnancy
- Risks of babies acquiring GBS through vaginal birth, preterm birth and C-section
- Maternal IV antibiotics (IAP) during labour to prevent GBS infection
- Impact on the infant microbiome of maternal IV antibiotics (IAP) for GBS
- How human milk oligosaccharides (HMOs) in breast milk can prevent GBS infection
- Risks and benefits of alternatives to antibiotics for preventing GBS infection
- News on a possible vaccine to prevent GBS infection in newborns
Usual price: AUD $132.00
Special discount offers available for Australian College of Midwives Members! Members can find the link here.
About the Presenters
Emeritus Professor Philip Steer
Phil Steer is currently Emeritus Professor of Obstetrics and Gynaecology in the Faculty of Medicine, Imperial College London, UK and consultant obstetrician at the Chelsea and Westminster Hospital in West London. His research interests are in the (patho)physiology of pregnancy and labour, and so far 18 of his research fellows have been awarded higher degrees. His clinical interests are in high risk pregnancy, maternal heart disease, and recurrent mid-trimester loss. He was President of the British Association of Perinatal Medicine 1996-9, Convener of meetings for the Royal College of Obstetricians and Gynaecologists 2004-6 (he organised the scientific programme for the 2007 British International Congress of O&G), and President of the Section of Obstetrics and Gynaecology of the Royal Society of Medicine 2007-8. He is a member of the Society of Authors and has published 112 original papers, 64 reviews and editorials and 56 book chapters; and co-edited three major textbooks (including High Risk Pregnancy- Management Options, now in its fourth edition).
Professor Anita Kozyrskyj
Dr Anita Kozyrskyj is Professor in the Department of Pediatrics, University of Alberta. Her epidemiological research uses population-based birth cohort studies with linkage to existing healthcare databases. Her research interests focus on early life programming of childhood atopic disease and overweight, as influenced by birth method, infant diet and antibiotic use during pregnancy, birth and infancy. Dr Kozryskyj is the PI of SyMBIOTA (Synergy in Microbiota) research program, one of the seven CIHR-funded Canadian Microbiome Initiative teams. The SyMBIOTA program, which derives its data from the 4-site CHILD (Canadian Healthy Infant Longitudinal Development) pregnancy cohort study, aims to investigate pre- and postnatal influences on infant gut microbiota and their connection to the development of atopy and overweight.
Jane Plumb MBE, Chief Executive, Group B Strep Support
Jane and husband Robert founded Group B Strep Support (GBSS) in 1996, following the death of their middle child. GBSS is an independent UK charity with a highly respected and independent medical advisory panel working to improve the prevention of group B Strep infections in babies, support and inform families affected by group B Strep and their health professionals, and support relevant research.
Jane has worked with many UK medical bodies, contributing to group B Strep relating consultations, and as a lay-representative on NICE guidelines/ Quality Standards. She provides patient input for research studies and the National Clinical Research Network Reproductive Health & Childbirth Speciality Group. She works closely with parliamentarians on improving group B Strep prevention policy. Jane was awarded an MBE for services to Child Healthcare in 2012.
Professor Victor Nizet
Victor Nizet is currently Professor and Vice Chair for Basic Research and Chief of the Division of Host-Microbe Systems & Therapeutics at the University of California, San Diego (UCSD), School of Medicine as well as Professor at UCSD Skaggs School of Pharmacy & Pharmaceutical Sciences.
Dr. Nizet is a graduate of Reed College, received his medical training at Stanford University School of Medicine, completed a Residency and Chief Residency in Pediatrics at Harvard University's Children's Hospital in Boston, Massachusetts, and a then a Fellowship in Pediatric Infectious Diseases at the University of Washington’s Children's Hospital in Seattle. Dr. Nizet leads a large basic and translational research laboratory focused on discovering virulence factors of invasive bacterial pathogens, elucidating mechanisms of host innate immunity, and novel approaches to infectious disease therapy or vaccines, with a longstanding interest in newborn infections and group B Streptococcus (GBS). Dr. Nizet has authored over 410 peer-reviewed publications, and has collaborated with several biotechnology interests in developing new antibiotic and immune-based therapies against drug-resistant pathogens. Dr. Nizet's work has been recognized by an American Heart Association Established Investigator Award, the American Lung Association Career Investigator Award, the American Asthma Foundation Senior Investigator Award, the E. Mead Johnson Award for Research in Pediatrics, and he been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the American Academy of Microbiology.
Meghan Azad, Assistant Professor, Dept. Pediatrics & Child Health, University of Manitoba
Assistant Professor, Department of Pediatrics & Child Health and Community Health Sciences, University of Manitoba; Associate Investigator, Canadian Healthy Infant Longitudinal Development (CHILD) Study, Research Scientist, Children’s Hospital Research Institute of Manitoba; co-Lead, Population Health Pillar, Developmental Origins of Chronic Diseases in Children Network (DEVOTION).
Dr Azad’s research focuses on the developmental origins of health and disease (DOHaD). Increasingly, early-life exposures are being linked to the development of non-communicable diseases throughout the life course. Perinatal exposures including parent lifestyle and diet, environmental chemicals, nutrition and the social environment have been identified as early determinants of chronic disorders including allergies, asthma, obesity, and cardiovascular disease. DOHaD research addresses these complex and long-term associations, seeking a better understanding of the underlying biological mechanisms with the ultimate goal of preventing disease through intervention during critical periods of early development.
Toni Harman, Course Creator & Programme Education Leader
Toni Harman is the co-producer / director of the multi award-winning film MICROBIRTH and co-author of the books, THE MICROBIOME EFFECT (Pinter & Martin 2016) and YOUR BABY’s MICROBIOME (Chelsea Green Publishing, Feb 2017). MICROBIRTH has been broadcast internationally and has won the Grand Prix Awards at both the Life Science Film Festival and the Ekotop Envirofilm Film Festival. Toni is also a professional speaker at international conferences about the science of the microbiome and epigenetics. As Educational Leader of the MICROBIRTH SCHOOL, Toni combines knowledge gained from researching the subject for six years with her extensive experience of running educational one-day and multiple-day workshops for adult learners.